IMDH inhibitors are a class of immunosuppressive drugs that help prevent organ transplant rejection by suppressing the immune system's activity. These drugs work by interfering with the synthesis of purine nucleotides, which are essential for the proliferation of immune cells, especially T-lymphocytes.
Role of IMDH inhibitors to prevent organ transplant rejections